If you want cheap medicine, Canadian taxpayers make it possible to get a great deal, but when it comes to new medicines, Canada is behind similar countries, according to a new report which ranks it 16th out of 18 comparable OECD countries.
Only 23% of 141 Health Canada-approved new medicines were included in public plans, ranking Canada 17 out of 18 there. Public drug plans in Canada make new medicines available only on a conditional, case-by-case basis, resulting in more administration, longer wait times for patients before beginning treatment, increased paperwork for physicians and no guarantee that patients will receive coverage.
The
report further notes that: